Since its establishment in 2002, "Biovit" has consistently increased its production capacity and expanded its product range, including both pharmaceuticals and dietary supplements. The entire production base of the company meets modern requirements, with the implementation of international GMP standards, and the quality control laboratory is accredited according to ISO 17025. The company’s products are exported to both neighboring and distant countries, which significantly contributes to the supply of the domestic market, as noted by "Kyrgyzpharm".
Talant Sultanov, director of GP "Kyrgyzpharm," emphasized the importance of partnership with domestic manufacturers: "The development of local production is not only an economic task but also a matter of national security and accessibility of medical services. By entering into agreements with companies like 'Biovit', we ensure the stability of supplies to medical institutions and reduce the financial burden on the healthcare system".
The first deliveries under the long-term contract are planned for the first quarter of 2026. In addition, opportunities for expanding cooperation are being considered, including contract manufacturing for government orders and the introduction of new drugs tailored to the needs of clinical practice in the country.
The initiative of GP "Kyrgyzpharm" to conclude direct agreements with national manufacturers is part of a broader strategy to modernize the system of public procurement of pharmaceuticals.
At "Kyrgyzpharm," it is emphasized that the agreement with "Biovit" is a step towards a new model of drug supply based on transparency, partnership, and prioritizing national interests.
